Trial intelligence / Profile preview

Open-label zonisamide adjunctive therapy in adults with partial-onset seizures

2005-001982-33Phase 4Completed

Sponsor
Eisai Co., Ltd.
Start
Aug 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of zonisamide in epilepsy, sponsored by Eisai Co., Ltd. Primary endpoint: Change in partial seizure frequency from baseline to end of week 19. Started Aug 2005; status: completed.

02

Drugs

zonisamide
03

Conditions

epilepsy

Beyond the preview

Go deeper on 2005-001982-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001982-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call